Abstract
The first successful use of bedaquiline for 18 months for XDR-TB as part of an optimised background regimen http://ow.ly/XE34x
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Diarylquinolines / administration & dosage*
-
Diarylquinolines / adverse effects
-
Diarylquinolines / therapeutic use
-
Drug Administration Schedule
-
Female
-
Humans
-
Safety
-
Tuberculosis, Multidrug-Resistant / drug therapy*
-
Young Adult
Substances
-
Diarylquinolines
-
bedaquiline